Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Colorcon
Medtronic
McKinsey
Merck

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Prednisolone acetate; sulfacetamide sodium - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for prednisolone acetate; sulfacetamide sodium and what is the scope of patent protection?

Prednisolone acetate; sulfacetamide sodium is the generic ingredient in ten branded drugs marketed by Allergan, Alcon, Schering, Pharmafair, Novartis, Akorn, and Bausch And Lomb, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-eight drug master file entries for prednisolone acetate; sulfacetamide sodium. One supplier is listed for this compound.

Summary for prednisolone acetate; sulfacetamide sodium
US Patents:0
Tradenames:10
Applicants:7
NDAs:11
Drug Master File Entries: 88
Suppliers / Packagers: 1
DailyMed Link:prednisolone acetate; sulfacetamide sodium at DailyMed
Pharmacology for prednisolone acetate; sulfacetamide sodium

US Patents and Regulatory Information for prednisolone acetate; sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon ISOPTO CETAPRED prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 087547-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Schering METIMYD prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 010210-002 Sep 9, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 088032-001 Apr 15, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088007-001 Apr 19, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Akorn PREDAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088059-001 Jul 29, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Dow
Moodys
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.